Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int Angiol ; 36(3): 268-274, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27598472

RESUMO

BACKGROUND: The purpose of this study was to evaluate the risks of bleeding, deep venous thrombosis (DVT), endovenous heat induced thrombosis (EHIT) and failure of ablation on patients who undergo ablation while on oral anticoagulation. METHODS: We compared 378 (3.4%) out of 11252 patients (group A) who had undergone 724 endovenous ablation of the saphenous veins from January 1, 2011 to September 30, 2014 while on oral anticoagulation to a randomly selected 375 patients (group B) who underwent 641endovenous ablation in the same time period but were not on anticoagulation. The demographic data, history of DVT, the Clinical, Etiologic, Anatomic, Pathologic (CEAP) classification and the VCSS (Venous Clinical Severity Score) scores were analyzed. The indications for anticoagulation, the anticoagulants used were recorded. The primary endpoints were bleeding, development of DVT or EHIT, and failure of ablation. RESULTS: Patients in group A were older, had more men, more history of DVT and PE, had higher CEAP and VCSS scores compared to group B. The type of anticoagulation used was warfarin in 77.2% direct oral inhibitors (DOIs) in 22.8%. The rate of failure of ablation at 3 days was 39 (5.6%) for Group A and 3 (0.5%) for Group B (P<0.0001) and at one month it was 46 (10.1%) vs. 27 (6.7%) (P=0.086). The number of EHIT cases in group A at 3 days was 2 (0.3%), compared to 6 (0.9%) in group B (P=0.016) and at 1 month it was 0 compared to 4 (1.0%) (P=0.0483). The DVT, SVT, hematoma and wound infection rates were similar in the two groups. CONCLUSIONS: Ablation of the saphenous veins in patients who are on oral anticoagulation is safe and does not increase the risk of bleeding or hematoma, but it may slightly lower the incidence of EHIT and increase the incidence of failure of ablation.


Assuntos
Técnicas de Ablação/efeitos adversos , Anticoagulantes/uso terapêutico , Veia Safena/cirurgia , Varizes/terapia , Insuficiência Venosa/terapia , Varfarina/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Hemorragia/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Resultado do Tratamento , Ultrassonografia Doppler Dupla , Estados Unidos , Trombose Venosa/epidemiologia , Adulto Jovem
2.
J Vasc Surg Venous Lymphat Disord ; 1(2): 159-64, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26992337

RESUMO

OBJECTIVE: Endovenous radiofrequency ablation has become an accepted mode of treatment for superficial venous reflux. In this study, we evaluated the incidence of endovenous heat-induced thrombosis (EHIT), its progression, and risk factors that may contribute to its formation. METHODS: This was a prospective study of all patients who underwent radiofrequency ablation of the great saphenous vein (GSV), accessory GSV, and small saphenous vein (SSV) from March 1, 2010, to September 30, 2011, from 12 of our affiliated vein centers in a primary vein practice. Demographic data, CEAP classification, previous history of deep venous thrombosis (DVT), body mass index, vein diameter, reflux time, catheter tip position, EHIT progression, number of stab phlebectomies, and Venous Clinical Severity Score of patients with EHIT were analyzed. RESULTS: Of the 6707 treated limbs, 4906 (73%) had GSV, 145 (2%) had accessory GSV, and 1656 (25%) had SSV ablation. EHIT developed in 201 limbs of 194 patients for an overall incidence of 3%. A nonfatal pulmonary embolism occurred in two patients (0.03%). Patients who developed EHIT were slightly older than those without EHIT (median age, 59 vs 56 years). In patients with EHIT, 34.8% were men, but only 25% were men among those who had no EHIT (P = .002). GSV, accessory GSV, and SSV diameters were larger in EHIT patients (P < .001 for all). Reflux time and catheter tip distance from the saphenous junctions were similar in those with and without EHIT. EHIT resolution occurred in 2 to 4 weeks in most patients, but EHIT worsening occurred in nine (4.5%) that all resolved ≤4 weeks. In the EHIT patients, 68% had multiple concomitant phlebectomies compared with 39.4% of those without EHIT (P < .0001). DVT history made no difference for EHIT development (P = .065). All but two class 1 and one class 2 EHIT patients were managed with observation and aspirin due to DVT history and physician concern. The Venous Clinical Severity Score was obtained only in the last 70 EHIT cases. The mean score was 5.92 preoperatively and improved to 2.08 at the 1-month follow-up. CONCLUSIONS: Large vein diameter, male sex, and multiple phlebectomies are risk factors for development of EHIT. We recommend that EHIT class 1 and 2 patients be managed with observation or antiplatelets, or both, but class 3 and 4 patients should be anticoagulated.

3.
J Vasc Surg ; 55(2): 529-31, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21958568

RESUMO

We report a case of a 58-year-old male patient who underwent successful endovenous radiofrequency ablation of the left great saphenous vein for CEAP class 4a venous disease. On the third postoperative day, he had a duplex ultrasound scan for evaluation which showed successful occlusion of the great saphenous vein (GSV) with class 2 endovenous heat-induced thrombus (EHIT) that disappeared during the evaluation and caused a pulmonary embolism. To our knowledge, no case of pulmonary embolism has been reported to occur during postoperative follow-up duplex scanning. Relevant literature is reviewed and a possible mechanism for thrombus dislodgement is entertained.


Assuntos
Ablação por Cateter/efeitos adversos , Temperatura Alta/efeitos adversos , Embolia Pulmonar/etiologia , Veia Safena/diagnóstico por imagem , Veia Safena/cirurgia , Ultrassonografia Doppler Dupla/efeitos adversos , Trombose Venosa/diagnóstico por imagem , Trombose Venosa/etiologia , Administração Oral , Anticoagulantes/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Pressão , Embolia Pulmonar/diagnóstico por imagem , Embolia Pulmonar/prevenção & controle , Fatores de Tempo , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Trombose Venosa/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...